Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma. Radiol Oncol [Internet]. 2025 Sep. 8 [cited 2026 Oct. 1];59(3):403-11. Available from: https://www.radioloncol.com/index.php/ro/article/view/4680